Tech Center 1600 • Art Units: 1611 1614 1616 1617
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18013174 | THERAPEUTIC AGENT FOR DRUG-INDUCED BRADYCARDIA AND BRADYARRHYTHMIA | Non-Final OA | NISSAN CHEMICAL CORPORATION |
| 18023594 | COMPOSITIONS AND METHODS FOR TREATING AMYLOID-RELATED CONDITIONS | Final Rejection | The Regents of the University of California |
| 18273708 | Materials and Methods for Treating Viral and Other Medical Conditions | Non-Final OA | Biotronik AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy